Provision of MagNA Pure 96
Public Health England (PHE) has awarded a contract to Roche Diagnostics Limited to procure MagNA Pure 96. This is part of a critical project to rapidly expand the SARS-CoV-2 sequencing capacity under the Genomics testing expansion slated for the 2nd half of 2021.
Buyer
Public Health England
Value
£358,297
Published
3 Jun 2021
Closes
26 Apr 2021
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Selective
Category
Goods
Contract starts
20 May 2021
Contract ends
20 May 2022
CPV classifications
33100000
Medical equipments
Lots
Lot default Provision of MagNA Pure 96
£358,297
Public Health England (PHE) has awarded a contract to Roche Diagnostics Limited to procure MagNA Pure 96. This is part of a critical project to rapidly expand the SARS-CoV-2 sequencing capacity under the Genomics testing expansion slated for the 2nd half of 2021.
Delivery: British Oversea Territories, Channel Islands, Europe, Isle of Man, Rest of the World, United Kingdom
Documents
Unlock document linkAwarded contract notice on Contracts Finder
3 Jun 2021
Awarded contract notice on Contracts Finder
Award notice · Web page
ECM_8238 - Fully signed - Order form - Redacted.ND.
Not provided
ECM_8238 - Fully signed - Order form - Redacted.ND.
Tender notice · PDF
Contains public sector information licensed under the Open Government Licence v3.0.